Iceland vs Naoero: New or unknown treatment history cases: Pulmonary, bacteriologically
Iceland
8
in 2022
Naoero
12
in 2023
Iceland rank
183rd
Naoero rank
180th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Iceland
- Naoero
How they compare
Naoero currently reports 12 against 8 in Iceland, a difference of 4.
That makes Naoero's figure about 1.5 times Iceland's.
The two have swapped places 2 times across 9 shared years of data; in 2014 it was Naoero ahead.
Iceland ranks 183rd and Naoero ranks 180th of 197 countries.
Naoero has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iceland | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.17 | 7 | 2.83 | Naoero |
| 2020s | 6 | 11.67 | 5.67 | Naoero |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Iceland or Naoero?
- Naoero, at 12 against 8 in Iceland as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Iceland and Naoero?
- 4, with Naoero ahead.
- How many years of comparable data are there for Iceland and Naoero?
- 9 years are reported by both, from 2014 to 2022.
- How do Iceland and Naoero rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Iceland ranks 183rd and Naoero ranks 180th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.